中央静脉阻塞:球囊成形术与支架置入的系统评价
该系统评价比较同侧血液透析通路合并中央静脉阻塞时,球囊成形术与支架置入的疗效。共纳入655例患者(456处狭窄、208处闭塞),支架置入组345例、球囊成形术组288例。支架置入在最初2年的一期通畅率优于球囊成形术,但两者12个月一期通畅率均低于60%,并发症均罕见(2%)。
要点
- 支架置入在最初2年的一期通畅率优于球囊成形术。
- 两种治疗12个月一期通畅率均低于60%,整体效果欠佳。
- 围手术期及长期并发症均罕见,发生率约2%。
核心结论
- 支架置入在最初2年的一期通畅率优于球囊成形术,且并发症发生率低,提示支架置入可作为中央静脉阻塞的一线治疗选择。
- 考虑到现有研究整体质量较差,即使这种短期的一期通畅率改善也可能使血液透析患者获益。
主要发现
- 最常受累的静脉为头臂静脉。
- 支架置入在最初2年的一期通畅率优于球囊成形术。
- 两种治疗12个月一期通畅率均低于60%。
- 辅助一期通畅率和二期通畅率在两种治疗间相似:球囊成形术12个月二期通畅率为77.8%至91.6%,支架置入为89.6%至98.4%。
- 两种干预的围手术期和长期并发症均罕见,发生于2%的患者。
临床怎么用
- 对于同侧血液透析通路合并中央静脉阻塞的患者,可考虑将支架置入作为一线治疗,因其在最初2年的一期通畅率更优且并发症发生率低。
- 需注意两种治疗12个月一期通畅率均低于60%,应个体化评估并密切随访。
局限性
- 现有研究整体质量较差。
- 需要随机对照试验以及评估药物涂层支架和球囊、抗凝治疗和血管内超声应用等辅助技术的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This review examines the evidence regarding treatment of central vein obstruction (CVO) in the setting of ipsilateral hemodialysis access. The aim of this work is to identify whether long-term venous patency after central vein stenting is superior compared with balloon venoplasty. To date, there are no evidence-based guidelines to direct the management of CVO in the setting of ipsilateral hemodialysis access. METHODS: An extensive systematic database search was performed using Medline, Embase, and the Cochrane Databases to identify all articles published from January 2000 to November 2019 comparing the management of CVO with venoplasty and/or stenting in the setting of ipsilateral hemodialysis access fistulae/grafts. RESULTS: There were 655 patients with 456 stenoses and 208 occlusions who were treated; 288 underwent venoplasty and 345 underwent stenting. Twenty-two patients failed intervention owing to an inability to traverse the occlusion. The most affected vein was the brachiocephalic vein. A superior primary patency (PP) is noted in those treated with stenting compared with venoplasty in the first 2 years. Overall, both treatments are suboptimal demonstrating a 12-month PP rate of less than 60%. Assisted PP and secondary patency rates were similar for both venoplasty and stenting with a 12-month secondary patency rate of 77.8% to 91.6% for venoplasty and 89.6% to 98.4% for stenting. Periprocedural and long-term complications were rare for both interventions, occurring in 2% of patients. CONCLUSIONS: Although both treatments demonstrated poor patency rates, greater PP is noted for stenting in the first 2 years. Coupled with low complication rates, this finding highlights a potential benefit of stenting as a first-line treatment for CVO. Allowing for the overall poor quality of current studies, even this short-term improvement in PP may benefit patients undergoing hemodialysis. Further research with randomised control trials as well as assessment of adjuvant techniques such as drug-coated stents and balloons, anticoagulant therapy, and the role of intravascular ultrasound use is required.
引用
- Andrawos A, Saeed H, Delaney C, et al. A systematic review of venoplasty versus stenting for the treatment of central vein obstruction in ipsilateral hemodialysis access. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 33667742. doi:10.1016/j.jvsv.2021.02.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。